Invesaro

Stocks Comparison

Cryo Cell International vs Progyny: revenue, profit, margins and growth compared

Cryo Cell International brought in $31.6M of revenue in fiscal 2025, Progyny $1.3B in fiscal 2025. Revenue changed by -1.3% at Cryo Cell International and +10.4% at Progyny on the year before, so Progyny grew faster. Cryo Cell International kept -7.7% of its revenue as net profit, Progyny 4.5%. Free cash flow was $5.2M at Cryo Cell International and $191.8M at Progyny.

Side by side, latest fiscal year

CCELPGNY
Fiscal year endedFY2025 (November 30, 2025)FY2025 (December 31, 2025)
Revenue$31.6M$1.3B
Revenue growth-1.3%+10.4%
Net income-$2.4M$58.5M
Net margin-7.7%4.5%
Free cash flow$5.2M$191.8M
Free cash flow margin16.6%14.9%
Earnings per share (diluted)-$0.30$0.65
Cash$319K$112.2M
Debt$8.4Mn/a
Price to earningsn/a39.1
Market value$34.2M$2B
Dividend yieldn/an/a
Rank by revenue in sector#412 of 646 · Health care#134 of 646 · Health care

Over the years

Revenue
CCEL FY2018: $29.2MCCEL FY2019: $31.8MCCEL FY2020: $31.1MCCEL FY2021: $28.9MCCEL FY2022: $30.3MCCEL FY2023: $31.3MCCEL FY2024: $32MCCEL FY2025: $31.6MPGNY FY2019: $105.4MPGNY FY2019: $229.7MPGNY FY2020: $344.9MPGNY FY2021: $500.6MPGNY FY2022: $786.9MPGNY FY2023: $1.1BPGNY FY2024: $1.2BPGNY FY2025: $1.3BFY18FY19FY20FY21FY22FY23FY24FY25
CCEL $31.6MPGNY $1.3B
Net income
CCEL FY2018: -$854.8KCCEL FY2019: $2.3MCCEL FY2020: $3.6MCCEL FY2021: $2.1MCCEL FY2022: $2.8MCCEL FY2023: -$9.5MCCEL FY2024: $402.1KCCEL FY2025: -$2.4MPGNY FY2019: $661KPGNY FY2019: -$8.6MPGNY FY2020: $46.5MPGNY FY2021: $65.8MPGNY FY2022: $30.4MPGNY FY2023: $62MPGNY FY2024: $54.3MPGNY FY2025: $58.5MFY18FY19FY20FY21FY22FY23FY24FY25
CCEL -$2.4MPGNY $58.5M
Net margin
CCEL FY2018: -2.9%CCEL FY2019: 7.2%CCEL FY2020: 11.6%CCEL FY2021: 7.2%CCEL FY2022: 9.1%CCEL FY2023: -30.4%CCEL FY2024: 1.3%CCEL FY2025: -7.7%PGNY FY2019: 0.6%PGNY FY2019: -3.7%PGNY FY2020: 13.5%PGNY FY2021: 13.1%PGNY FY2022: 3.9%PGNY FY2023: 5.7%PGNY FY2024: 4.7%PGNY FY2025: 4.5%FY18FY19FY20FY21FY22FY23FY24FY25
CCEL -7.7%PGNY 4.5%
Revenue growth
CCEL FY2019: +8.9%CCEL FY2020: -2.1%CCEL FY2021: -7.3%CCEL FY2022: +5.0%CCEL FY2023: +3.3%CCEL FY2024: +2.0%CCEL FY2025: -1.3%PGNY FY2019: +117.9%PGNY FY2020: +50.1%PGNY FY2021: +45.2%PGNY FY2022: +57.2%PGNY FY2023: +38.3%PGNY FY2024: +7.2%PGNY FY2025: +10.4%FY19FY20FY21FY22FY23FY24FY25
CCEL -1.3%PGNY +10.4%
Free cash flow
CCEL FY2018: $4.9MCCEL FY2019: $5.6MCCEL FY2020: $8.4MCCEL FY2021: $6.1MCCEL FY2022: -$3.6MCCEL FY2023: $2.1MCCEL FY2024: $3.6MCCEL FY2025: $5.2MPGNY FY2019: $1.7MPGNY FY2019: -$4.5MPGNY FY2020: $35.2MPGNY FY2021: $23.9MPGNY FY2022: $77.2MPGNY FY2023: $185.2MPGNY FY2024: $173.7MPGNY FY2025: $191.8MFY18FY19FY20FY21FY22FY23FY24FY25
CCEL $5.2MPGNY $191.8M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cryo Cell International and Progyny

Which is bigger by revenue, Cryo Cell International or Progyny?

Progyny is bigger by revenue: $1.3B in fiscal 2025, against $31.6M for Cryo Cell International in fiscal 2025.

Which keeps more of its revenue as profit, Cryo Cell International or Progyny?

Cryo Cell International had a net margin of -7.7% in fiscal 2025; Progyny had 4.5% in fiscal 2025.

Which grew revenue faster, Cryo Cell International or Progyny?

In their latest fiscal years revenue changed by -1.3% at Cryo Cell International and +10.4% at Progyny.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies